Contract with Customer, Liability, Noncurrent of POINT Biopharma Global Inc. from 31 Dec 2021 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
POINT Biopharma Global Inc. quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Dec 2021 to 30 Sep 2023.
  • POINT Biopharma Global Inc. Contract with Customer, Liability, Noncurrent for the quarter ending 30 Sep 2023 was $3,720,881.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)

POINT Biopharma Global Inc. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $3,720,881 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $3,197,547 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $7,444,239 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $10,178,147 +$10,178,147 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q4 2021 $0 31 Dec 2021 10-K 27 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.